{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T07:31:38Z","timestamp":1782804698419,"version":"3.54.5"},"reference-count":41,"publisher":"Georg Thieme Verlag KG","issue":"02","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Thromb Hemost"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Our objective was to review the maternal characteristics and obstetric complications in women with type 2B von Willebrand disease (VWD). A systematic literature search was conducted using PubMed, Scopus, Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov. We included all publications that addressed type 2B VWD in pregnancy. Our primary and secondary outcomes were incidence of postpartum hemorrhage (PPH) and incidence of thrombocytopenia in pregnancy. Two reviewers independently identified eligible studies and abstracted data including maternal characteristics, hematologic characteristics, treatment, and delivery outcomes. Twenty studies met inclusion criteria. There were 27 women (32 pregnancies) with type 2B VWD. Primary PPH was reported in 9\/20 women (45%) and secondary PPH was reported in 6\/13 women (46%). Thrombocytopenia in pregnancy was present in 27\/28 women (96%); 23\/27 women (85%) had platelet count &lt;100\u2009\u00d7\u2009109\/L, mean 33.7\u2009\u00b1\u200922.7\u2009\u00d7\u2009109\/L. Factor concentrate treatment was administered before delivery (n\u2009=\u200916) and postpartum (n\u2009=\u200918), some women received both. Seventeen deliveries required blood products postpartum with 13\/17 (76%) platelet transfusions and 6\/17 (35%) red blood cell transfusions. No maternal mortality was reported. Women with type 2B VWD have significant morbidity in pregnancy related to high incidence of severe thrombocytopenia and primary and secondary PPH.<\/jats:p>","DOI":"10.1055\/s-0041-1723799","type":"journal-article","created":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T00:31:57Z","timestamp":1614385917000},"page":"201-216","source":"Crossref","is-referenced-by-count":14,"title":["Type 2B von Willebrand Disease in Pregnancy: A Systematic Literature Review"],"prefix":"10.1055","volume":"47","author":[{"given":"Mona M.","family":"Makhamreh","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa L.","family":"Russo","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Warren Alpert Medical School of Brown University, Women and Infants Hospital of Rhode Island, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"Karl","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Delgado","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Lackritz","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel W.","family":"Skupski","sequence":"additional","affiliation":[{"name":"Departments of Obstetrics and Gynecology, Weill Cornell Medicine, New York, New York, and New York Presbyterian-Queens, Flushing, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huda B.","family":"Al-Kouatly","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2021,2,26]]},"reference":[{"issue":"10","key":"ref1","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand factor","volume":"4","author":"J E Sadler","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"02","key":"ref2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","article-title":"von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)","volume":"14","author":"W L Nichols","year":"2008","journal-title":"Haemophilia"},{"issue":"06","key":"ref3","doi-asserted-by":"crossref","first-page":"e0179566","DOI":"10.1371\/journal.pone.0179566","article-title":"Type 2B von Willebrand disease with or without large multimers: a distinction of the two sides of the disorder is long overdue","volume":"12","author":"A Casonato","year":"2017","journal-title":"PLoS One"},{"issue":"12","key":"ref4","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1182\/blood-2017-06-742692","article-title":"How I treat type 2B von Willebrand disease","volume":"131","author":"R Kruse-Jarres","year":"2018","journal-title":"Blood"},{"issue":"04","key":"ref5","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1172\/JCI115122","article-title":"Molecular basis of von Willebrand disease type IIB. Candidate mutations cluster in one disulfide loop between proposed platelet glycoprotein Ib binding sequences","volume":"87","author":"A M Randi","year":"1991","journal-title":"J Clin Invest"},{"issue":"06","key":"ref6","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1182\/blood.V59.6.1272.1272","article-title":"Multimeric composition of factor VIII\/von Willebrand factor following administration of DDAVP: implications for pathophysiology and therapy of von Willebrand's disease subtypes","volume":"59","author":"Z M Ruggeri","year":"1982","journal-title":"Blood"},{"issue":"02","key":"ref7","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1055\/s-0037-1613992","article-title":"Impact, diagnosis and treatment of von Willebrand disease","volume":"84","author":"J E Sadler","year":"2000","journal-title":"Thromb Haemost"},{"issue":"11","key":"ref8","doi-asserted-by":"crossref","first-page":"e112935","DOI":"10.1371\/journal.pone.0112935","article-title":"Complex changes in von Willebrand factor-associated parameters are acquired during uncomplicated pregnancy","volume":"9","author":"D N Drury-Stewart","year":"2014","journal-title":"PLoS One"},{"issue":"03","key":"ref9","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1182\/blood-2008-04-152280","article-title":"Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patients","volume":"113","author":"A B Federici","year":"2009","journal-title":"Blood"},{"issue":"03","key":"ref10","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1365-2516.2011.02691.x","article-title":"Pregnancy in type 2B VWD: a case series","volume":"18","author":"A Ranger","year":"2012","journal-title":"Haemophilia"},{"issue":"04","key":"ref11","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2516.2006.01314.x","article-title":"The obstetric and gynaecological management of women with inherited bleeding disorders\u2014review with guidelines produced by a taskforce of UK Haemophilia Centre Doctors' Organization","volume":"12","author":"C A Lee","year":"2006","journal-title":"Haemophilia"},{"issue":"01","key":"ref12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijgo.2010.11.011","article-title":"FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age","volume":"113","author":"M G Munro","year":"2011","journal-title":"Int J Gynaecol Obstet"},{"issue":"04","key":"ref13","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1097\/AOG.0000000000002351","article-title":"183: postpartum hemorrhage","volume":"130","author":"Committee on Practice Bulletins-Obstetrics","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"03","key":"ref14","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.1097\/AOG.0000000000003100","article-title":"207: thrombocytopenia in pregnancy","volume":"133","author":"Committee on Practice Bulletins\u2014Obstetrics","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"02","key":"ref15","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/jp.2008.141","article-title":"Platelet reference ranges for neonates, defined using data from over 47,000 patients in a multihospital healthcare system","volume":"29","author":"S E Wiedmeier","year":"2009","journal-title":"J Perinatol"},{"issue":"07","key":"ref16","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"D Moher","year":"2009","journal-title":"PLoS Med"},{"key":"ref17","first-page":"88","article-title":"Von Willebrand disease from the viewpoint of obstetrician\u2014case studies","volume":"35","author":"M Zembala-Szczerba","year":"2015","journal-title":"Ginekologia i Poloznictwo"},{"issue":"02","key":"ref18","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.tjog.2009.12.003","article-title":"Ovarian hyperstimulation syndrome associated with von Willebrand's disease","volume":"50","author":"P H Chen","year":"2011","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"06","key":"ref19","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1097\/00000542-200412000-00029","article-title":"Severe thrombocytopenia, type 2B von Willebrand disease and pregnancy","volume":"101","author":"D L Hepner","year":"2004","journal-title":"Anesthesiology"},{"issue":"01","key":"ref20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1365-2516.2003.00712.x","article-title":"Type 2B vWD: the varied clinical manifestations in two kindreds","volume":"9","author":"P Mathew","year":"2003","journal-title":"Haemophilia"},{"issue":"01","key":"ref21","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1365-2141.1990.tb02621.x","article-title":"Spontaneous platelet aggregation during pregnancy in a patient with von Willebrand disease type IIB can be blocked by monoclonal antibodies to both platelet glycoproteins Ib and IIb\/IIIa","volume":"75","author":"F I Pareti","year":"1990","journal-title":"Br J Haematol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0028-2243(90)90067-B","article-title":"Severe thrombocytopenia in a pregnant patient with platelet-associated IgM and known von Willebrand's disease; a case report","volume":"36","author":"F A Valster","year":"1990","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"03","key":"ref23","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1182\/blood.V69.3.786.786","article-title":"Thrombocytopenia associated with pregnancy in a patient with type IIB von Willebrand's disease","volume":"69","author":"M E Rick","year":"1987","journal-title":"Blood"},{"issue":"01","key":"ref24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00001721-199102000-00005","article-title":"Pregnancy-induced worsening of thrombocytopenia in a patient with type IIB von Willebrand's disease","volume":"2","author":"A Casonato","year":"1991","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"02","key":"ref25","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1067\/mob.2001.106764","article-title":"Maternal and fetal outcomes in pregnancies affected by von Willebrand disease type 2","volume":"184","author":"J Burlingame","year":"2001","journal-title":"Am J Obstet Gynecol"},{"issue":"01","key":"ref26","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1111\/hae.12580","article-title":"Management of pregnancy in type 2B von Willebrand disease: case report and literature review","volume":"21","author":"E Biguzzi","year":"2015","journal-title":"Haemophilia"},{"issue":"03","key":"ref27","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/bjh.13395","article-title":"First report of inhibitory von Willebrand factor alloantibodies in type 2B von Willebrand disease","volume":"171","author":"M Baaij","year":"2015","journal-title":"Br J Haematol"},{"issue":"02","key":"ref28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/ejh.13250","article-title":"Pregnancy and delivery in women with von Willebrand disease","volume":"103","author":"G Castaman","year":"2019","journal-title":"Eur J Haematol"},{"issue":"03","key":"ref29","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1471-0528.1998.tb10093.x","article-title":"Pregnancy in women with von Willebrand's disease or factor XI deficiency","volume":"105","author":"R A Kadir","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"issue":"05","key":"ref30","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/AOG.0b013e3181a09fc0","article-title":"Overview of maternal morbidity during hospitalization for labor and delivery in the United States: 1993-1997 and 2001-2005","volume":"113","author":"C J Berg","year":"2009","journal-title":"Obstet Gynecol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1700541","article-title":"Type 3 von Willebrand disease in pregnancy: a systematic literature review","author":"M M Makhamreh","year":"2019","journal-title":"Am J Perinatol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"100633","DOI":"10.1016\/j.blre.2019.100633","article-title":"Maternal and neonatal bleeding complications in relation to peripartum management in women with Von Willebrand disease: a systematic review","volume":"39","author":"M C Punt","year":"2020","journal-title":"Blood Rev"},{"issue":"01","key":"ref33","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-2393-13-16","article-title":"Pseudo (platelet-type) von Willebrand disease in pregnancy: a case report","volume":"13","author":"N Grover","year":"2013","journal-title":"BMC Pregnancy Childbirth"},{"issue":"02","key":"ref34","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1177\/1753495X17720626","article-title":"Management of pregnancy and emergency caesarean delivery in a patient with type IIB von Willebrand disease and severe preeclampsia: a case report and literature review","volume":"11","author":"D Martingano","year":"2018","journal-title":"Obstet Med"},{"issue":"02","key":"ref35","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000453389","article-title":"Management of type 2B von Willebrand disease during pregnancy","volume":"137","author":"D McLaughlin","year":"2017","journal-title":"Acta Haematol"},{"issue":"04","key":"ref36","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1160\/TH13-06-0462","article-title":"Characterisation of the p.A1461D mutation causing von Willebrand disease type 2B with severe thrombocytopenia, circulating giant platelets, and defective \u03b1-granule secretion","volume":"111","author":"F Langer","year":"2014","journal-title":"Thromb Haemost"},{"issue":"02","key":"ref37","first-page":"163","article-title":"Precise diagnosis by gene analysis and successful management of delivery in three patients with type IIB von Willebrand disease","volume":"60","author":"T Takafuta","year":"1994","journal-title":"Int J Hematol"},{"issue":"01","key":"ref38","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/ajh.2830350107","article-title":"Effect of a factor VIII concentrate on type IIB von Willebrand's disease-associated thrombocytopenia presenting during pregnancy in identical twin mothers","volume":"35","author":"M Ieko","year":"1990","journal-title":"Am J Hematol"},{"issue":"03","key":"ref39","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1365-2141.1987.tb02356.x","article-title":"Type IIB von Willebrand's disease presenting as thrombocytopenia during pregnancy","volume":"67","author":"A R Giles","year":"1987","journal-title":"Br J Haematol"},{"issue":"02","key":"ref40","first-page":"282","article-title":"Pregnancy in women with different types of von Willebrand disease","volume":"68","author":"M Conti","year":"1986","journal-title":"Obstet Gynecol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"100572","DOI":"10.1016\/j.blre.2019.04.001","article-title":"Evolution of replacement therapy for von Willebrand disease: from plasma fraction to recombinant von Willebrand factor","volume":"38","author":"F Peyvandi","year":"2019","journal-title":"Blood Rev"}],"container-title":["Seminars in Thrombosis and Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0041-1723799.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T00:37:38Z","timestamp":1614386258000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0041-1723799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,26]]},"references-count":41,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2021,2,26]]},"published-print":{"date-parts":[[2021,3]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0041-1723799","relation":{},"ISSN":["0094-6176","1098-9064"],"issn-type":[{"value":"0094-6176","type":"print"},{"value":"1098-9064","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,26]]}}}